| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 3.204 | 4.144 | 3.799 | 24.950 | 325 |
| Total Income - EUR | - | - | - | - | 0 | 6.233 | 4.144 | 42.022 | 24.974 | 31.741 |
| Total Expenses - EUR | - | - | - | - | 796 | 4.984 | 3.826 | 50.307 | 9.444 | 90.211 |
| Gross Profit/Loss - EUR | - | - | - | - | -796 | 1.249 | 318 | -8.285 | 15.530 | -58.471 |
| Net Profit/Loss - EUR | - | - | - | - | -796 | 1.153 | 194 | -8.884 | 13.457 | -58.471 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cardiomedive Healthcare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 243 | 34.818 |
| Current Assets | - | - | - | - | 74 | 7.373 | 8.086 | 6.023 | 58.285 | 102.219 |
| Inventories | - | - | - | - | 0 | 2.024 | 3.129 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 72 | 497 | 4.936 | 4.754 | 8.954 | 70.903 |
| Cash | - | - | - | - | 2 | 4.852 | 21 | 1.268 | 49.331 | 31.316 |
| Shareholders Funds | - | - | - | - | -753 | 413 | 598 | -8.121 | 57.693 | -1.101 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 203 | 2.022 | 2.010 |
| Debts | - | - | - | - | 827 | 6.959 | 7.487 | 14.144 | 835 | 89.136 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 49.002 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Cardiomedive Healthcare S.r.l.